FA
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination | NPJ Vaccines |  | 2020 | 415 | 98 | ||
| A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner | Frontiers in immunology | | 2020 | 200 | 70 | ||
| Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centers | Cell Reports | | 2019 | 232 | 144 | ||
| Site-specific DC surface signatures influence CD4+ T cell co-stimulation and lung-homing | Frontiers in Immunology | | 2019 | 242 | 145 | ||
| Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation | Frontiers in Immunology | | 2019 | 226 | 109 | ||
| Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlan | Frontiers in Immunology | | 2018 | 416 | 388 | ||
| Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report | The New England journal of medicine | | 2016 | 817 | 237 | ||
| The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial | Lancet. Infectious diseases |  | 2015 | 638 | 0 | ||
| MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life | The Journal of immunology | | 2015 | 561 | 2 | ||
| Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept | Vaccine | | 2015 | 576 | 126 | ||
| Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants | The Journal of immunology | | 2012 | 560 | 0 |
